Similar Papers

Paper Title
Journal
Date
Author
Transcription of proteinase 3 and related myelopoiesis genes in peripheral blood mononuclear cells of patients with active Wegener's granulomatosis.
Chris Cheadle ... Stuart M Levine
Arthritis & Rheumatism | VOL. 62
Chris Cheadle, et. al.Chris Cheadle ... Stuart M Levine
28 May 2010
Circulating B Cells, Plasma Cells, and Treg Associate with ANCA Levels in ANCA-associated Vasculitis
Joaquin Manrique ... Paolo Cravedi
Kidney International Reports | VOL. 6
Joaquin Manrique, et. al.Joaquin Manrique ... Paolo Cravedi
20 Nov 2020
POS-138 SEVERE INFECTIONS IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS: CLINICO-BACTERIOLOGICAL PROFILE AND RISK FACTORS
N Cherni ... T Ben Abdallah
Kidney International Reports | VOL. 6
N Cherni, et. al.N Cherni ... T Ben Abdallah
01 Apr 2021
ATYPICAL VARIANT OF GRANULOMATOSIS WITH POLYANGIITIS WITH EOSINOPHILIA
Krishna Shah ... Afoma King
Chest | VOL. 162
Krishna Shah, et. al.Krishna Shah ... Afoma King
01 Oct 2022
View more papers

More From: RMD Open

Paper Title
Journal
Date
Author
Influence of sacroiliac joint variation on clinical features of axial spondyloarthritis: a comparative analysis
Carolina Dominguez Aleixo ... Fabian Proft
RMD Open | VOL. 11
Carolina Dominguez Aleixo, et. al.Carolina Dominguez Aleixo ... Fabian Proft
08 Feb 2025
OMERACT GCA phantom project: validation of a 3D-printed ultrasound training phantom for diagnosis of giant cell arteritis
Tobias Schremmer ... Valentin Sebastian Schäfer
RMD Open | VOL. 11
Tobias Schremmer, et. al.Tobias Schremmer ... Valentin Sebastian Schäfer
06 Feb 2025
Porphyromonas gingivalis associates with the presence of anti-citrullinated protein antibodies, but not with the onset of arthritis: studies in an at-risk population
Charlotte De Vries ... Karin Lundberg
RMD Open | VOL. 11
Charlotte De Vries, et. al.Charlotte De Vries ... Karin Lundberg
31 Jan 2025
Long-term safety and sustained efficacy of bimekizumab in patients with ankylosing spondylitis (radiographic axial spondyloarthritis): 5-year results from BE AGILE (phase 2b) and its open-label extension
Atul Deodhar ... Xenofon Baraliakos
RMD Open | VOL. 11
Atul Deodhar, et. al.Atul Deodhar ... Xenofon Baraliakos
31 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.